VIUM
Vium, Inc.
Trademark Registered: 2017-05-30
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86982214 |
| Registration Number | 5215140 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Connie L. Ellerbach, Esq. |
| Attorney Docket Number | 31009-00070 |
| Law Office Assigned | L70 |
| Employee Name | BUTLER, MIDGE FAE |
Timeline
| 2016-02-09 | Application Filed |
| 2016-05-04 | Date of First Use |
| 2016-08-09 | Published for Opposition |
| 2017-04-21 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-05-30 | Status: Live/Registered |
| 2017-05-30 | Trademark Registered |
| 2019-04-11 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  VIUM, INC. |
| Address | 441 BOREL AVENUE, SUITE 616 SAN MATEO DE 94402 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Laboratory analysis in the field of genotyping and phenotyping of animals, laboratory animal scientific research and testing; Laboratory research in the field of genotyping and phenotyping of animals; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of genotyping and phenotyping of animals; laboratory animal scientific research and testing; research and development of pharmaceuticals and biologics; scientific testing of pharmaceuticals and biologics; biopharmaceutical research design and scientific testing services; product safety testing for pharmaceuticals, biopharmaceuticals, and biologics; toxicological safety testing services for pharmaceuticals; animal medical research and testing services for the purpose of medical research; research and development of pharmaceuticals, biotechnology, and biochemicals; platform as a service (PAAS) featuring computer software platforms for conducting preclinical research in the field of animal scientific research and testing and development of pharmaceuticals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing non-clinical trials and studies on pharmaceuticals for others; scientific consulting services for others in the field of non-clinical trials and studies on pharmaceuticals; collection, calibration, analysis and reporting of medical and scientific research data in connection with non-clinical trials and studies on pharmaceuticals; scientific research and analysis in the fields of bioinformatics, biomarkers and phenotyping; computer hardware and software design; development, updating and maintenance of software and databases; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical development studies; providing online computer databases in the fields of research and development of pharmaceuticals, biotechnology, and biochemicals; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from non-clinical trials and studies on pharmaceuticals; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals; providing online non-downloadable software for designing, conducting, analyzing, and reporting animal studies |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-02-12 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-02-12 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2016-05-25 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2016-06-02 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2016-06-02 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-06-02 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-06-15 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2016-06-22 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-06-23 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-06-23 | 10 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-06-26 | 11 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-07-05 | 12 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-07-20 | 13 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-08-09 | 14 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-08-09 | 15 NPUB E:E-Mail |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2016-08-10 | 16 ASGN I:Incoming Correspondence |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2016-10-04 | 17 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2017-03-30 | 18 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2017-03-30 | 19 EEXT I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2017-03-30 | 20 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2017-04-20 | 21 AITU A:Allowance for Publication |
| EXTENSION 1 FILED | 2017-03-30 | 22 EXT1 S: |
| EXTENSION 1 GRANTED | 2017-04-20 | 23 EX1G S: |
| DIVISIONAL REQUEST RECEIVED | 2017-03-30 | 24 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2017-04-20 | 25 DPCC D:Assigned to Examiner |
| USE AMENDMENT FILED | 2017-03-30 | 26 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2017-04-20 | 27 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-04-21 | 28 EXRA E:E-Mail |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2017-04-21 | 29 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2017-04-22 | 30 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2017-05-30 | 31 R.PR A:Allowance for Publication |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2019-04-11 | 32 EWAF I:Incoming Correspondence |
| REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED | 2019-04-11 | 33 CORV 4: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-06 | 34 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-06 | 35 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-06 | 36 TCCA I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2020-08-19 | 37 ASGN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-05-30 | 38 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2023-12-15 | 39 C8.. O:Outgoing Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 